ArticleBMC infectious diseases2025
Perceived usability, acceptability, and feasibility of stool-based qPCR TB diagnostics: perspectives from healthcare providers in Manhiça District, southern Mozambique.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.The Lancet. Infectious diseases · 2026Trial
- Article
- Exploring non-sputum biosignatures for tuberculosis triage and diagnosis in children living with HIV.Expert review of molecular diagnostics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundStool-based qPCR TB diagnostics (S-qPCR TBD) are reported to contribute to increased rates of bacteriological confirmation in children and people living with HIV. However, there is still limited literature on the usability, acceptability, and feasibility of S-qPCR TBD in countries with high TB burden. This study aimed to assess healthcare providers' perspectives on usability and perceived barriers and facilitators to the uptake of S-qPCR TBD.
methodsThis generic qualitative study was conducted across five health facilities and four communities within the Manhiça District (Mozambique). Twenty-one semi-structured interviews combined with direct observations were conducted with HPs from February 2022 to March 2023. The interviews were transcribed, coded using an Excel matrix, and analyzed using the Diffusion of Innovation theory and the socioecological framework.
resultsThe findings suggest that HPs view S-qPCR TBD as easy to perform and beneficial for patients who struggle with sputum production. Intrapersonal factors, such as prior experiences with biological sampling procedures, traumatic experiences with invasive procedures, and understanding of clinical outcomes, are crucial factors positively influencing acceptability. Institutional factors, namely, the clarity of information about S-qPCR TBD, and community factors, such as collaboration between community leaders and health services to facilitate patient referral, were also identified as critical. Societal factors, such as the definition of national guidelines, also play a role. However, potential barriers were identified. These include intrapersonal factors like level of education, employment, distance to health facilities, lack of experience with Stool-based Procedures, and misconceptions about and fears of handling stools. Institutional challenges, such as a lack of clear explanation of the technique, as well as resources and training, delays in consumable replenishment, and machine breakdowns, could also hinder acceptance. Local beliefs about TB transmission also play a role as community-level factors.
conclusionsWhile HPs consider S-qPCR TBD as beneficial and easy to perform, acceptability may be compromised by factors such as patients' characteristics, health services challenges, lack of awareness about the S-qPCR TBD, and misconceptions about stool samples and TB. To promote acceptability, the study suggests disseminating information about TB and S-qPCR TBD, improving trust in health services, and fostering collaboration between the health sector and community actors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.